BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3477869)

  • 21. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups.
    Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T
    Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.
    Cervantes F; Hernández-Boluda JC; Steegmann JL; Conde E; Alvarez-Larrán A; López-Jiménez J; Osorio S; Villalón L; Camós M; García-Conde J; Odriozola J
    Haematologica; 2003 Oct; 88(10):1117-22. PubMed ID: 14555307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.
    Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H
    Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of elderly patients with acute myeloid leukemia.
    Pulsoni A; Pagano L; Latagliata R; Casini M; Cerri R; Crugnola M; De Paoli L; Di Bona E; Invernizzi R; Marmont F; Petti MC; Rigolin G; Ronco F; Spadano A; Tosti ME; Visani G; Mele A; Mandelli F
    Haematologica; 2004 Mar; 89(3):296-302. PubMed ID: 15020267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Retrospective study of acute myelogenous leukemia in 83 elderly patients: clinical and biological characteristics].
    Tsuzuki M; Ino T; Hasegawa A; Miyazaki H; Kojima H; Maruyama F; Okamoto M; Matsui T; Ezaki K; Hirano M
    Rinsho Ketsueki; 2000 Apr; 41(4):296-302. PubMed ID: 10846459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex karyotypes confer a poor survival in adult acute myeloid leukemia with unfavorable cytogenetic abnormalities.
    Chen CC; Yang CF; Lee KD; You JY; Yu YB; Ho CH; Tzeng CH; Chau WK; Hsu HC; Gau JP
    Cancer Genet Cytogenet; 2007 Apr; 174(2):138-46. PubMed ID: 17452256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
    Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
    Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.
    Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF
    Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
    Doubek M; Palasek I; Brychtova Y; Buchtova I; Mayer J
    Neoplasma; 2005; 52(5):411-4. PubMed ID: 16151586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
    Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
    Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic implication of clinical and histological features in Ph1+ chronic myelocytic leukaemia (CML).
    Thiele J; Fohlmeister I; Vonneguth B; Zankovich R; Fischer R
    Anticancer Res; 1986; 6(6):1401-9. PubMed ID: 3468880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ
    Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relevance of clinical and laboratory data at diagnosis to survival time of chronic granulocytic leukemia patients.
    Kotlarek-Haus S; Frydecka I; Koprowska G; Kuliczkowski K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):731-7. PubMed ID: 2436985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia.
    Dekmezian R; Kantarjian HM; Keating MJ; Talpaz M; McCredie KB; Freireich EJ
    Cancer; 1987 May; 59(10):1739-43. PubMed ID: 2435399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases.
    Fenaux P; Beuscart R; Lai JL; Jouet JP; Bauters F
    J Clin Oncol; 1988 Sep; 6(9):1417-24. PubMed ID: 3166485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of accelerated disease in chronic myelogenous leukemia.
    Kantarjian HM; Dixon D; Keating MJ; Talpaz M; Walters RS; McCredie KB; Freireich EJ
    Cancer; 1988 Apr; 61(7):1441-6. PubMed ID: 3162181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Four autopsy cases of atypical leukemia in the higher age bracket resembling chronic myelogenous leukemia (author's transl)].
    Nemoto K; Ohnishi Y
    Rinsho Ketsueki; 1977 Dec; 18(12):1414-21. PubMed ID: 272474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.